Skip to content

The Purity Number Is Not the Verdict: Reading HPLC Data in a Documented Materials Audit

A single percentage on a certificate of analysis can travel a long way — into a lab notebook, a procurement file, a grant report, a supplier review. Knowing precisely what that number does and does not cover is what separates a tidy audit trail from a false sense of assurance.

What an HPLC purity percentage actually reports

When a certificate states that a lyophilised research peptide is ≥99% pure by HPLC, the figure is almost always a relative area percentage taken from a UV chromatogram at a stated wavelength. It describes the proportion of UV-absorbing peak area attributed to the target compound against other integrated peaks in that particular run. It is not an absolute assay, not a mass balance, and not a statement that 99% of the powder in the vial is the target molecule. Research Sciences publishes a ≥99% verified purity line on its homepage and notes in its FAQs that the exact purity for a given product is stated on the CoA; that wording should be treated as the shop’s current published claim and reconfirmed against the batch document rather than quoted as a standalone specification.

The distinction matters because UV response depends on chemical structure. Two species present in equal mass can produce very different peak areas, and species without a chromophore at the detection wavelength may not register at all. Water content, residual solvents, counter-ions and formulation excipients are effectively invisible to the method. The FAQs from Research Sciences note that its peptides contain trace amounts of mannitol as an excipient, used to support lyophilisation stability, solubility and storage protection — a legitimate detail that no HPLC purity percentage will capture. Trifluoroacetate counter-ions and residual salts sit outside the figure in the same way. Nor does a percentage describe particle form, residual moisture or the homogeneity of the fill across a batch.

What the figure genuinely supports

Used well, the number remains valuable. It gives a like-for-like comparison between batches produced by the same method, flags gross failure or visible degradation, and — when a reference standard is run alongside the sample — supports peak identification by retention time. For a materials audit it functions as a screening signal and a consistency check, not a ceiling on quality and not a guarantee of identity.

What it leaves silent

Identity confirmation beyond retention matching, endotoxin load, heavy-metal content, residual moisture and any statement about sterility all sit outside the chromatogram. Research Sciences describes full-spectrum testing as covering purity, identity, heavy metals and endotoxin evaluation, with CoAs linked to supported products, but a reader should verify exactly which tests are recorded on the specific batch certificate rather than assume every parameter appears on every document. None of the above makes any material suitable for human or veterinary use; all products are supplied strictly for controlled laboratory and analytical research.

Matching the certificate to the vial in your hand

Audits fail less often on the science than on the paperwork. A purity figure earns its keep only when it can be tied to the physical container being used. Research Sciences labels vials with a reference combining SKU code and expiry date — for example BPC10-03/27 — which links to the corresponding CoA, and that reference should be quoted when contacting the shop about documentation. Goods-in records should capture the reference, the certificate version or filename, and the date of receipt, so that a reviewer can move from bench record to certificate without guesswork.

Restocks carry a subtlety worth flagging to materials managers. The FAQs state that restocked products may carry the same Internal Test Reference (ITR) as earlier stock, and that an ITR links to associated sample testing reports. It does not confirm that separate deliveries come from the same production lot, nor that separate independent testing has been performed on a later delivery. Vial cap colours and other packaging may also vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. For a defensible file, log each delivery as its own entry even where the ITR is unchanged, and record the batch reference actually printed on the vial in front of you.

Goods-in filing is where many audit trails quietly unravel. A laboratory that sources research materials such as Uk peptides for in-vitro work should ensure the certificate is filed with the goods-in entry rather than in a separate folder, so that the batch reference, the storage record and the usage log all point to a single document. When a vial is opened, the date and the assay context should be added to the same record.

The homepage lists “CoAs Janoshik Analytical Reports” among its published claims, and the FAQs describe a CoA for every product covering purity and identity by HPLC. These are the shop’s current published terms: they should be reconfirmed on the live site and, more importantly, on the batch certificate itself. Independent verification means reading the document that accompanies the specific vial, not the headline on the category page.

Questions HPLC cannot answer — and what to add to the audit

A well-designed audit form asks the chromatogram only what it can support, then sources the rest elsewhere. Several questions are worth adding. Which analytical method and detection wavelength produced the figure, and is that recorded on the certificate? Was identity confirmed by a technique beyond retention time? Were heavy metals and endotoxin screened for this batch, and where is the result recorded? What is the moisture content, and does it shift the effective concentration in an in-vitro assay? Which excipients are present — the shop’s FAQs note trace mannitol — and could they interfere with the readout? And what storage history applies between dispatch and the bench? Each answer belongs in the same file as the purity percentage, otherwise the figure floats free of context.

Storage is part of the audit, not an afterthought. The published handling guide asks that lyophilised peptides be held at −20°C or below, sealed with desiccant and protected from moisture, heat and light, and that repeated freeze–thaw cycles be avoided; reconstituted material is described as less stable and should be kept at 2–8°C for short-term laboratory use. Record the date each vial is opened and the diluent volume used for an in-vitro concentration step. The reconstitution calculator on product pages exists for that laboratory arithmetic alone, and the shop states that neither the calculator nor the materials are intended for human or veterinary dosing.

Finally, restate the boundary inside the file itself. Research Sciences labels products “For Research Use Only – Not for Human Consumption” and describes this as in line with MHRA guidance, which is the shop’s stated position and not legal advice. Materials are not medicines, medical devices, supplements or injectables, are not for human or veterinary use, and the purchaser carries responsibility for lawful use, safe handling, storage, disposal and COSHH compliance, as well as for confirming that a product suits the intended research application. A purity figure supports the analytical narrative of an audit; it says nothing about contaminants the method cannot see, about identity on its own, or about suitability for any use beyond controlled laboratory research.